Viewpoint Articles
The 8 most recent years have been the warmest on record [ 1 ]. In 2022, the global 10-year average temperature soared to 1.15 °C above preindustrial levels. The climate change impacts from heat waves, floods, and droughts are more apparent and direct when compared with the circuitous and indirect ...
Malnutrition, which continues to affect hundreds of millions of people worldwide, is both a cause and consequence of a range of infectious diseases. In this perspective piece, we provide an overview of the bidirectional relationship between malnutrition and infectious diseases. In addition to ...
Three and a half years into the coronavirus disease 2019 (COVID-19) pandemic, the nature and durability of protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) still remains unclear. Current COVID-19 mRNA vaccines have been shown to provide minimal protection against ...
Best of the IDSA Journals 2023
As we usher in the new year, the IDSA journals would like to thank all the excellent authors and peer reviewers that have contributed their expertise in 2023. The Editors-in-Chief of Clinical Infectious Diseases, The Journal of Infectious Diseases, and Open Forum Infectious Diseases have each selected 5 articles that represent significant contributions in their fields. We invite you to explore the sample of impressive research online.
Journal of Infectious Diseases Viewpoints
The Journal of Infectious Diseases has launched a new series of papers, JID Viewpoints. These short, pithy pieces will provide expert views on timely and intriguing issues infectious diseases scientists need to know about now. Read the latest JID Viewpoints below.
Lessons from a House on Fire – From Smallpox to Polio
Mpox Evolution: Has the Current Outbreak Revealed a Pox on “U”?
JID Now Offers Review Pathway for Papers Rejected by High-Impact Journals
The Journal of Infectious Diseases welcomes papers that have been peer reviewed by another medical journal and were not accepted for publication, where the authors believe they can address the essential concerns identified by previous reviewers. Under this new pathway, authors can revise the paper according to the review comments they previously received and then submit the paper to JID. This new pathway is intended to speed publication and minimize unnecessary re-review of papers that previously received thorough and detailed review elsewhere.
Latest Supplements
Explore the latest supplements from JID:
Mpox: Challenges and Opportunities Following the Global 2022 Outbreak
Read the supplement
Preparing Europe for Introduction of Immunization Against RSV: Bridging the Evidence and Policy Gap
Read the supplement
10th International Symposium on Filoviruses
Read the supplement
Author Resources
Interested in publishing with JID?
Read the author guidelines to learn more about the JID submission process, and then submit your paper using our online submission system.
Open Access
Authors interested in publishing in JID may be able to publish their paper open access using funds available through their institution's agreement with OUP.
Publishing Process Support
Whether you are preparing your manuscript for submission, are wondering what to do once your manuscript has been accepted or are trying to find out how to promote your article, we have general resources to help you along the way.How to Write a Publishable Manuscript
Watch Dr. Martin S. Hirsch's presentation on writing successful manuscripts.
IDSA Thanks Retiring JID Editors
As the term of Martin S. Hirsch, MD, FIDSA, as editor-in-chief of The Journal of Infectious Diseases ends, the Infectious Diseases Society of America wishes to thank him and all members of his editorial board for their extraordinary work as journal and Society leaders.
IDSA Information
The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases.
Stay Connected
The IDSA Journals app gives you the freedom to read The Journal of Infectious Diseases both online and offline, on your iPad, iPhone, or iPod Touch.
Register for email alerts and get notified as soon as new issue is published online.
